INFLUENZA VACCINE

Brand Owner (click to sort) Address Description
ACTIVAX AMERICAN CYANAMID COMPANY Wayne NJ Influenza Vaccine;
ALPHAHIB SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 influenza vaccine;
DORVAC Sandoz, Inc. East Hanover NJ INFLUENZA VACCINE;
FLU ENZ AMERICAN HOME PRODUCTS CORPORATION New York NY influenza vaccine;FLU;
FLUAD CHIRON CORPORATION 4560 Horton Street Emeryville CA 946082916 influenza vaccine;
FLUAD NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. Via Florentina 1 53100 Siena Italy influenza vaccine;FLUID;
H-FLU-B AMERICAN CYANAMID COMPANY Wayne NJ Influenza Vaccine;H FLU B;
HIB-IMUNE AMERICAN CYANAMID COMPANY Wayne NJ INFLUENZA VACCINE;
HIBSTART SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 influenza vaccine;
HIBTECT SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 influenza vaccine;
INFLUJECT Baxter Vaccine AG Industriestrasse 67 Vienna A-1220 Austria INFLUENZA VACCINE;INFLUENZA INJECTION;
KIDDIHIB SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 influenza vaccine;KIDDI-HIB KIDDY HIB;
KIDIHIB SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 influenza vaccine;
MIX-IMUNE AMERICAN CYANAMID COMPANY Wayne NJ an Influenza Vaccine;
MYX-IMUNE AMERICAN CYANAMID COMPANY Wayne NJ an Influenza Vaccine;IMMUNE;
OMNIHIB SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 influenza vaccine;
SUBUVAC Sandoz, Inc. East Hanover NJ INFLUENZA VACCINE;
ULTRAHIB SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 influenza vaccine;ULTRA HIB;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides a monovalent influenza vaccine comprising a low dose of egg-derived influenza virus antigen from an influenza virus strain that is associated with a pandemic outbreak or has the potential to be associated with a pandemic outbreak, in combination with an aluminium adjuvant. The invention also provides vaccine kits comprising a combination of a parenteral and a mucosal influenza vaccine, wherein the combined dose of antigen is no more than the conventional antigen dose. Also provided are methods for preparing the vaccines.